Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Alirocumab Injection

Alisizumab is a fully human monoclonal antibody (IgG1 isotype) used primarily for the prevention of cardiovascular events and the regulation of primary hypercholesterolemia (including heterozygous familial and non-familial) and mixed dyslipidemia.
In adult patients diagnosed with atherosclerotic cardiovascular disease, it can reduce the risk of myocardial infarction, stroke, and unstable angina requiring hospitalization.
It can be used as an adjunct to diet for the treatment of adult patients with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia to reduce low-density lipoprotein cholesterol (LDL-C) levels.


Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.